You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

CLINICAL TRIALS PROFILE FOR SUFENTANIL CITRATE


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for SUFENTANIL CITRATE

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00738192 ↗ Comparison of Analgesic Efficacy of Fentanyl, Sufentanil and Butorphanol After Remifentanil Anesthesia Completed Nanjing Medical University Phase 4 2008-07-01 Fast awakening from anesthesia is one of the major characteristics of remifentanil-associated anesthetic induction and maintenance, whereas corresponding pain during awakening influences patient's rehabilitation strongly. In addition, such early postoperative pain results in significant stress responses, which displays as further release of stress hormones such as cortisol and β-endorphin as well. How to prevent such acute pain resulting from remifentanil's fast metabolism endows clinical significance. This study is designed to compare the analgesic efficacy of fentanyl, sufentanil and butorphanol delivered after gynecological laparoscopic surgeries that underwent remifentanil induction and maintenance, and investigate corresponding influence on the levels of blood cortisol and β-endorphin.
NCT02604797 ↗ Analgesia Effects of Nalbuphine vs Sulfentanil Unknown status Fudan University N/A 2016-01-01 Cesarean section may result in great trauma and postoperative pain. Besides incision pain, uterine contraction pain is another source of postoperative pain after cesarean section. In clinical practice, a large amount of uterine contraction agent is routinely applied after cesarean section so as to promote involution of uterus and reduce postoperative hemorrhage, which also causes great uterine contraction pain. Acute pain is the risk factor of chronic pain, and may postpone the recovery from labour and influence the quality of life of parturient. Though various analgesia modules have been attempted, more than 20% parturients still experience severe postoperative pain, and pain management after cesarean section remains a challenge to anesthesiologists. This study aim to compare the effects of nalbuphine hydrochloride vs sufentanil citrate on patient-controlled intravenous analgesia after cesarean section.
NCT03685188 ↗ Oxycodone and Sufentanil for Analgesia in Hip Surgery Enrolling by invitation West China Hospital Phase 4 2018-12-01 We design this randomized controlled trial to compare the safety and efficacy of Oxycodone and Sufentanil for postoperative patient-controlled analgesia in patients undergoing hip surgery, with a view to finding the optimal postoperative analgesic regime with fewer adverse reactions and promoting patients' rehabilitation.
NCT05529875 ↗ Comparison of Propofol and Sevoflurane Anesthesia on the Quality of Recovery After Ambulatory Surgery in Obese Patients Withdrawn Jiangang Song N/A 2022-10-01 This study was designed to compare propofol intravenous anesthesia to sevoflurane inhalation anesthesia on the quality of recovery after surgery for anal fistula in obese patients. Propofol-based total intravenous anesthesia (TIVA) and sevoflurane inhalation anesthesia are the two main anesthesia techniques. Obesity influences not only anesthetics metabolic but also physical function of patients, so it is meaningful to study which anesthesia technique is better for the recovery of obese patients after surgery.
NCT05548465 ↗ Long-term-opioid-free Anesthesia in Anterior Cervical Surgery Enrolling by invitation West China Hospital Phase 4 2022-09-20 We design this randomized controlled trial to explore the safety and efficacy of the long-term-opioid-free anesthesia in anterior cervical surgery, to reduce the dosage of perioperative long-acting opioids and promoting patients'rehabilitation.
NCT05596071 ↗ Whether Opioids Are Factor That Induced POD? Completed Zhejiang Cancer Hospital N/A 2016-06-25 The purpose of this study was to investigate whether perioperative use of low doses of opioids could reduce postoperative delirium .
NCT05831345 ↗ Intraoperative Methadone for the Prevention of Postoperative Pain Recruiting Brugmann University Hospital Phase 3 2023-02-28 The pain felt after orthopedic surgery in the absence of adequate locoregional anesthesia is often insufficiently controlled, especially during the first 24 hours postoperatively. Methadone, due to its long half-life, may provide better pain control after orthopedic surgery when associated locoregional anesthesia cannot be performed. It may be impossible to perform loco-regional anesthesia in various contexts: patient refusal, pre-existing neurological impairment, infection at the injection site, coagulopathies, inability to cooperate, total language barrier, allergy to anesthetics, unavailability of equipment (ultrasound, etc.) or equipped room, lack of experience of nursing staff in performing the block and in the postoperative management of the patient. Intraoperative administration of methadone in these settings may be superior to sufentanil for pain control during the 24 hours post orthopedic surgery, and the pain control provided by methadone does not appear to imply a higher likelihood of adverse events related to opioids.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for SUFENTANIL CITRATE

Condition Name

Condition Name for SUFENTANIL CITRATE
Intervention Trials
Analgesia, Patient-Controlled 1
C.Delivery; Surgery (Previous), Gynecological 1
Long-term-opioid-free Anesthesia 1
Orthopedic Surgery 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for SUFENTANIL CITRATE
Intervention Trials
Pain, Postoperative 2
Rectal Fistula 1
Delirium 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for SUFENTANIL CITRATE

Trials by Country

Trials by Country for SUFENTANIL CITRATE
Location Trials
China 5
Belgium 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for SUFENTANIL CITRATE

Clinical Trial Phase

Clinical Trial Phase for SUFENTANIL CITRATE
Clinical Trial Phase Trials
Phase 4 3
Phase 3 1
N/A 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for SUFENTANIL CITRATE
Clinical Trial Phase Trials
Completed 2
Enrolling by invitation 2
Unknown status 1
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for SUFENTANIL CITRATE

Sponsor Name

Sponsor Name for SUFENTANIL CITRATE
Sponsor Trials
West China Hospital 2
Nanjing Medical University 1
Fudan University 1
[disabled in preview] 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for SUFENTANIL CITRATE
Sponsor Trials
Other 7
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.